second-line - Globe Thesis

Keyword [second-line] Result: 121 - 137 \| Page: 7 of 7
121.	A Comparative Study Of First-and Second-line Application Of Nilotinib In Patients With Chronic Myeloid Leukemia In The Chronic Phase
122.	A Real World Study Of Second-line Chemotherapy For Advanced Small Intestinal Adenocarcinoma
123.	Single-Center Retrospective Study Of Case Series On Efficacy Of First-Line And Second-Line Treatment For Chronic Graft-Versus-Host Disease
124.	Effect Of Nutritional Intervention On Second-line Chemotherapy For Advanced Gastric Cancer
125.	Comparison Of The Efficacy And Safety Of ICIs With Rh-endostatin Versus ICIs With Chemotherapy For The Second-line Treatment Of Advanced NSCLC
126.	Efficacy And Safety Analysis Of Apatinib Combined With Immune Checkpoint Inhibitors And Chemotherapy In Second Line Treatment Of Advanced Cholangiocarcinoma
127.	Comparative Efficacy And Safety Of Second-line Immune Checkpoint Inhibitors After The Process Of First-line Chemotherapy In Patients With Advanced Non-small Cell Lung Cancer: A Network Meta-analysis
128.	Comparison Of Efficacy And Safety Of Regorafenib With Or Without PD-1 Inhibitors In The Second-line Treatment Of Advanced Hepatocellular Carcinoma
129.	Effect And Efficacy Analysis Of Second-line And Multi-line Treatmentof Anlotinib Combined With PD-1 Inhibitor On Coagulation Function In Patients With Non-small Cell Lung Cancer
130.	Efficacy And Safety Of Anlotinib Combined With Docetaxel In Second-line Treatment Of Extensive Small Cell Lung Cancer
131.	Efficacy Of Apatinib In Patients With Second-line Chemotherapy Failure,Driver Gene Wild Type,Performance Status Of 3 Score,advanced Non-small-cell Lung Cancer
132.	Evaluation Of Therapeutic Effect And Survival Analysis Of Fuzheng Jiedu Heluo Therapy In The Treatment Of Advanced Lung Squamous Cell Carcinoma
133.	A Study On Drug Preference Of Type 2 Diabetes Patients In North And South China
134.	Retrospective Analysis On The Clinical Significance Of PD-1 Inhibitor In The Second-line Treatment Of Advanced Esophageal Squamous Cell Carcinoma In The Real World
135.	Effect Of Metformin Combined With Second-Line Hypoglycemic Drugs On The Prognosis Of Coronary Heart Disease Complicated With Type 2 Diabetes
136.	Short-term Clinical Observation And Meta Analysis Of Efficacy And Safety Of PD-1 Inhibitor Combined With Anlotinib In Second-line Treatment Of Advanced Esophageal Squamous Cell Carcinoma
137.	A Clinical Study Of Anrotinib Hydrochloride Combined With Aidi Injection In Patients With Advanced Or Recurrent Non-small Cell Lung After Second-line Treatment
<<First <Prev Next> Last>> Jump to